Chromocell Therapeutics Corporation (CHRO) — Defensive Interval Ratio
Chromocell Therapeutics Corporation (CHRO) has a Defensive Interval Ratio of 2 days as of June 2025. Defensive assets of $40.40K (cash $-, short-term investments $-, receivables $40.40K) cover 2 days of daily cash needs of $20.05K/day. Check CHRO goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Chromocell Therapeutics Corporation Defensive Interval Ratio (2024–2024)
This chart shows how Chromocell Therapeutics Corporation's Defensive Interval Ratio has evolved across 1 annual periods from 2024 to 2024. As of June 2025, the ratio stands at 2 days, meaning defensive assets of $40.40K can fund 2 days of operations without new revenue. Also explore net asset growth rate of Chromocell Therapeutics Corporation to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Chromocell Therapeutics Corporation (2024–2024)
The table below presents the year-by-year Defensive Interval Ratio for Chromocell Therapeutics Corporation from 2024 to 2024, covering 1 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market cap of Chromocell Therapeutics Corporation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 4 days | $40.40K | $11.19K/day | $- | $- | — |